The Chemical and Pharmaceutical Industry in China: Opportunities and Threats for Foreign Companies

Gunter Festel; Andreas Kreimeyer; Udo Oels; Max Von Zedtwitz

doi:10.1007/b137786

The Chemical and Pharmaceutical Industry in China: Opportunities and Threats for Foreign Companies

Gunter Festel^* (Editor), Andreas Kreimeyer (Editor), Udo Oels (Editor), Max Von Zedtwitz (Editor)

^*Corresponding author for this work

Research output: Book/Report › Anthology › Research › peer-review

Abstract

The Chinese market and Chinese companies are of increasing importance for the global chemical and pharmaceutical industry. The book starts with the characterization of the chemical and pharmaceutical industry in China. One central aspect is the political and economic situation in China with its strategic and operational implications for Western chemical and pharmaceutical companies. A major part of the book comprises case studies describing how Western companies like BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing the market entry and investments for further growth in China. The book also analyzes the threat to Western companies in their home markets from Chinese competitors.

First-hand information about China and strategies of Western companies for market entry and investment. With many case examples from Western companies in China.

Original language	English

Place of Publication	Berlin
Publisher	Springer
Number of pages	295
ISBN (Print)	3540225447, 9783540225447, 9783642061400
ISBN (Electronic)	9783540265610
DOIs	https://doi.org/10.1007/b137786
Publication status	Published - 2005
Externally published	Yes

Access to Document

10.1007/b137786Licence: Unspecified

Handle.net

Persistent link

Cite this

@book{7837bde7b0b347aaa98ff98712fc9b09,

title = "The Chemical and Pharmaceutical Industry in China: Opportunities and Threats for Foreign Companies",

abstract = "The Chinese market and Chinese companies are of increasing importance for the global chemical and pharmaceutical industry. The book starts with the characterization of the chemical and pharmaceutical industry in China. One central aspect is the political and economic situation in China with its strategic and operational implications for Western chemical and pharmaceutical companies. A major part of the book comprises case studies describing how Western companies like BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing the market entry and investments for further growth in China. The book also analyzes the threat to Western companies in their home markets from Chinese competitors.First-hand information about China and strategies of Western companies for market entry and investment. With many case examples from Western companies in China.",

editor = "Gunter Festel and Andreas Kreimeyer and Udo Oels and {Von Zedtwitz}, Max",

year = "2005",

doi = "10.1007/b137786",

language = "English",

isbn = "3540225447",

publisher = "Springer",

address = "Germany",

}

TY - BOOK

T1 - The Chemical and Pharmaceutical Industry in China

T2 - Opportunities and Threats for Foreign Companies

A2 - Festel, Gunter

A2 - Kreimeyer, Andreas

A2 - Oels, Udo

A2 - Von Zedtwitz, Max

PY - 2005

Y1 - 2005

N2 - The Chinese market and Chinese companies are of increasing importance for the global chemical and pharmaceutical industry. The book starts with the characterization of the chemical and pharmaceutical industry in China. One central aspect is the political and economic situation in China with its strategic and operational implications for Western chemical and pharmaceutical companies. A major part of the book comprises case studies describing how Western companies like BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing the market entry and investments for further growth in China. The book also analyzes the threat to Western companies in their home markets from Chinese competitors.First-hand information about China and strategies of Western companies for market entry and investment. With many case examples from Western companies in China.

AB - The Chinese market and Chinese companies are of increasing importance for the global chemical and pharmaceutical industry. The book starts with the characterization of the chemical and pharmaceutical industry in China. One central aspect is the political and economic situation in China with its strategic and operational implications for Western chemical and pharmaceutical companies. A major part of the book comprises case studies describing how Western companies like BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing the market entry and investments for further growth in China. The book also analyzes the threat to Western companies in their home markets from Chinese competitors.First-hand information about China and strategies of Western companies for market entry and investment. With many case examples from Western companies in China.

U2 - 10.1007/b137786

DO - 10.1007/b137786

M3 - Anthology

AN - SCOPUS:84892137656

SN - 3540225447

SN - 9783540225447

SN - 9783642061400

BT - The Chemical and Pharmaceutical Industry in China

PB - Springer

CY - Berlin

ER -